Table 3.
A. baumannii clinical isolates and their antibiotic resistance patterns, organized by year
| Parameter | Total | 2015 | 2016 | p |
|---|---|---|---|---|
| Sample, n (%) | ||||
| Respiratory tract specimens | 34 (73.9) | 17 (85) | 17 (65.4) | |
| Blood | 7 (15.2) | 0 | 7 (26.9) | |
| Pus from wounds | 3 (6.5) | 2 (10) | 1 (3.8) | |
| Urine | 2 (4.3) | 1 (5) | 1 (3.8) | |
| Antimicrobial resistance profile, n (%) | ||||
| Tigecycline | 34 (73.9) | 10 (50) | 24 (92.3) | 0.002* |
| Levofloxacin | 42 (91.3) | 16 (80) | 26 (100) | 0.030* |
| Amikacin | 45 (97.8)) | 19 (95) | 26 (100) | 0.435 |
| Amoxicillin/Clavulanate | 46 (100) | 20 (100) | 26 (100) | |
| Ampicillin/Sulbactam | 44 (95.7) | 18 (90) | 26 (100) | 0.184 |
| Aztreonam | 46 (100) | 20 (100) | 26 (100) | |
| Cefepime | 46 (100) | 20 (100) | 26 (100) | |
| Cefixime | 46 (100) | 20 (100) | 26 (100) | |
| Ceftazidime | 46 (100) | 20 (100) | 26 (100) | |
| Ceftriaxone | 46 (100) | 20 (100) | 26 (100) | |
| Ciprofloxacin | 44 (95.7) | 19 (95) | 25 (96.2) | 0.686 |
| Colistin | 1 (2.2) | 0 (0) | 1 (3.8) | 0.380 |
| Ertapenem | 45 (97.8) | 19 (95) | 26 (100) | 0.435 |
| Gentamicin | 44 (95.7) | 19 (95) | 25 (96.2) | 0.686 |
| Imipenem | 45 (97.8) | 19 (95) | 26 (100) | 0.435 |
| Meropenem | 45 (97.8) | 19 (95) | 26 (100) | 0.435 |
| Nitrofurantion | 45 (97.8) | 19 (95) | 26 (100) | 0.435 |
| Piperacillin/Tazobactam | 46 (100) | 20 (100) | 26 (100) | |
| Trimethoprim/Sulfamethoxazole | 27 (58.7) | 19 (95) | 8 (30.8) | <0.001* |
*P < 0.05